Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News CSL Seqirus data show cell-based flu vaccine provides 20% stronger protection against lab-confirmed influenza Find out how CSL Seqirus’s real-world data reveal a 20% protection boost for its cell-based flu vaccine over traditional egg-based shots. bySoujanya RaviOctober 21, 2025